Reading Time: 4 minutes

Rheumatoid arthritis (RA), a chronic and debilitating condition, has been a focal point of medical research for decades. Traditional treatments, including the use of gold salts known as aurothiolates, have seen a decline due to their adverse effects and questionable long-term efficacy. However, a pioneering study conducted by Drs. Peter B. Himmel, Jorge D. Flechas, and Guy E. Abraham proposes a revolutionary shift back to a form of gold treatment, but with a modern twist: colloidal gold.

The Resurgence of Gold in RA Treatment

The historical use of gold in treating RA dates back to the early 20th century, with aurothiolates being introduced by Forestier in 1929. Despite their initial promise, these treatments fell out of favor due to severe side effects and a lack of enduring benefits. Enter colloidal gold: a nanoparticle form of gold proposed to offer the therapeutic benefits of aurothiolates without the detrimental side effects. This study explores the hypothesis that colloidal gold, generated in vivo from aurothiolates, is the actual therapeutic agent in RA treatment.

Study Overview

In an effort to validate the therapeutic potential of colloidal gold, a pilot study was launched involving 10 patients with long-standing, erosive RA. These patients, who had seen little to no improvement with previous treatments, were administered oral doses of colloidal gold (Aurasol-tm) ranging from 30 to 60 mg daily for one month. The study meticulously tracked clinical improvements and monitored potential toxicity.

Findings: A Ray of Hope

The results were compelling. Within just one week, patients experienced statistically significant reductions in joint tenderness and swelling, improvements that persisted throughout the study. Fatigue levels dropped, and patients reported increased satisfaction in their ability to perform daily activities. Remarkably, these improvements came without any signs of gold toxicity, a stark contrast to the side effects associated with traditional gold salt therapies.

Beyond Symptom Relief: The Mechanisms at Play

Further investigations into the mechanism behind colloidal gold’s effectiveness revealed suppression of inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFa), suggesting a direct impact on the inflammatory processes driving RA. These findings support the hypothesis that colloidal gold acts at a cellular level, potentially stabilizing lysosomes within phagocytes and synovial cells, thereby exerting its therapeutic effects.

A Safer Alternative to Traditional Therapies

The study’s implications are far-reaching, positioning colloidal gold as a potentially safer and more effective alternative to conventional gold-based therapies for RA. With no clinical or laboratory evidence of toxicity observed, colloidal gold stands out as a promising treatment avenue for patients who have exhausted other options.


The groundbreaking study on the use of colloidal gold in treating rheumatoid arthritis not only revisits the therapeutic potential of gold in a modern context but also opens the door to safer and more effective treatment alternatives for patients suffering from this chronic condition. The significant reductions in joint tenderness and swelling, alongside the absence of toxic side effects, underline the promise of colloidal gold as a revolutionary treatment modality in rheumatology.

As we stand on the brink of what could be a new era in the management of rheumatoid arthritis, further research and controlled trials are imperative to fully understand and harness the potential of colloidal gold. This study is a beacon of hope, suggesting that an ancient remedy, refined by modern science, could bring relief to millions of RA patients worldwide.

For those interested in a deeper dive into the specifics of this study, including methodology, detailed findings, and the scientific underpinnings of colloidal gold’s effects on rheumatoid arthritis, you can read the full study here:

Remember, the pursuit of knowledge is a journey that often revisits the past to forge the future. This study not only highlights the importance of revisiting and reevaluating previous treatment methodologies but also emphasizes the continual need for innovation in medical science.